Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal)

  • Technology appraisal
  • TA207
  • Published: 

History

Documents created during the development process.

Background information

Mantle cell lymphoma (relapsed) - temsirolimus: final scope

Mantle cell lymphoma (relapsed) - temsirolimus: final matrix

Mantle cell lymphoma (relapsed) - temsirolimus: Institute's response to consultee and commentator comments on the draft scope

Mantle cell lymphoma (relapsed) - temsirolimus: Institute's response to consultee and commentator comments on the provisional matrix